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i g h l i g h t s
We describe an optimized high-content assay to simultaneously measure oxidative stress-induced -synuclein aggregation and cell death in human
neuronal cell lines.
The presented method allows the quantiﬁcation of both -synuclein inclusion formation and apoptosis in an automated, objective and reproducible
manner.
The high-content assay can contribute to the identiﬁcation of compounds and genes that might alter -synuclein aggregation and toxicity.
a b s t r a c t
Background: Alpha-synuclein (-SYN) aggregates represent a key feature of Parkinson’s disease, but
the exact relationship between -SYN aggregation and neurodegeneration remains incompletely
understood. Therefore, the availability of a cellular assay that allows medium-throughput analysis of
-SYN-linked pathology will be of great value for studying the aggregation process and for advancing
-SYN-based therapies.
Newmethod:Herewedescribe ahigh-contentneuronal cell assay that simultaneouslymeasures oxidative
stress-induced -SYN aggregation and apoptosis.
Results: We optimized an automated and reproducible assay to quantify both-SYN aggregation and cell
death in human SH-SY5Y neuroblastoma cells.
Comparison with existing methods: Quantiﬁcation of -SYN aggregates in cells has typically relied on
manual imagingandcountingor cell-free assays,whichare timeconsuminganddonot allowaconcurrent
analysis of cell viability. Our high-content analysismethod for quantiﬁcation of-SYNaggregation allows
simultaneous measurements of multiple cell parameters at a single-cell level in a fast, objective and
automated manner.
Conclusions: The presented analysis approach offers a rapid, objective and multiparametric approach for
the screening of compounds and genes that might alter -SYN aggregation and/or toxicity.
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105. Introduction
Parkinson’s disease (PD) is a progressive, neurodegenerative
isorder characterized by a loss of dopaminergic neurons in the
ubstantia nigra pars compacta. The protein alpha-synuclein (-
YN) is considered a key player in synucleinopathies, including PD
Deleersnijder et al., 2013). First, aggregated -SYN is a major con-
tituentof LewyBodies, i.e. eosinophilic cytoplasmic inclusions that
re a pathological hallmark of PD (Spillantini et al., 1997). Second,
issense mutations in the -SYN gene (A53T, A30P, E46K, G51D
ndH50Q) (Appel-Cresswell et al., 2013; Kruger et al., 1998; Lesage
t al., 2013; Polymeropoulos et al., 1997; Zarranz et al., 2004) and
ocus duplication (Chartier-Harlin et al., 2004; Ibanez et al., 2004)
r triplication (Singleton et al., 2003) of the wild type (WT) gene
ere identiﬁed as cause of autosomal-dominant monogenetic PD.
inally, overexpression of WT and mutant forms of -SYN in C.
legans, Drosophila, mice, rats and non-human primates leads to
euronal inclusions and/or behavioral symptoms very similar to
hose observed in PD patients. (Eslamboli et al., 2007; Feany and
ender, 2000; Kirik et al., 2003, 2002; Lakso et al., 2003; Lauwers
t al., 2003; Oliveras-Salva et al., 2013; Van der Perren et al., 2014).
Although research on PD has accelerated in the last decade due
o increased insight in the pathogenic mechanisms (Gasser, 2009;
ubbe and Morris, 2014; Mizuno et al., 2008; Olanow and Brundin,
013), there is still a lack of efﬁcient and robust cell culture mod-
ls. Such assays could speed up the discovery of new candidate
nhibitors of PD pathology and in particular of -SYN aggrega-
ion.We developed an oxidative stress-induced cellular model of
-SYN aggregation in human SH-SY5Y neuroblastoma cells, fol-
owed by high-content image-based analysis to simultaneously
uantify -SYN aggregate formation and cell death (Aelvoet et al.,
014; Deleersnijder et al., 2011; Gerard et al., 2010; Oliveras-Salvá
t al., 2014;VanderVekenet al., 2012).High-content analysis (HCA)
s the process of extracting complex information from images of
ells and tissues using a combination of automated microscopy
nd automated image analysis (Denner et al., 2008; Dragunow,
008; Rausch, 2005). HCA has already been successfully applied to
etermine several aspects of the brain’s complexity, such as neu-
ite outgrowth (Radio, 2012; Vallotton et al., 2007; Wang et al.,
010), neurogenesis (Blackmore et al., 2010), cell count (Narayan
t al., 2007), inclusion formation (Boyd et al., 2014; Scotter et al.,
008; Teboul et al., 2007), apoptosis (Dragunowet al., 2006; Fennell
t al., 2006), cell migration (Schmandke et al., 2013) and signal
ransduction (Grimsey et al., 2008). To our knowledge, this tech-
ology has not been used yet to study -SYN aggregation, while
t has several advantages over manual methods of -SYN aggre-
ate analysis. Most cellular studies thus far have been based on
stimating the intensity of Thioﬂavin S (Thio S) staining in cells
r on manual counting of -SYN inclusion formation, which are
oth slow, subjective and laborious methods. Moreover, manual
ethods do not allow to discriminate between changes in aggre-
ate size ordensity and changes in aggregatenumber. Furthermore,
lthough biochemical and biophysical techniques (e.g. gel ﬁltra-
ion, low speed or analytical centrifugation, transmission electron
icroscopy, structural stability, protease resistance, turbidity, cir-
ular dichroism and immunological investigations) can provide
seful information on the size and the nature of the -SYN aggre-
ates, they lack cellular resolution and/or concurrent analysis of
ell health or simply do not allow for bigger throughput (Harper
nd Lansbury, 1997; Lundvig et al., 2005). Additionally, routine
pplication of most of the aforementioned techniques in large-
cale assays for therapeutically relevant interactions or promising
rug therapies is not feasible. Our HCA method for quantifying -
YN aggregation circumvents the caveats listed above as it allows
imultaneous measurements of multiple cell characteristics at a
ingle-cell level in a fast, objective and automated manner. Thepresented analysis platform offers a rapid, objective and multipa-
rametric approach for the validation of compounds and genes that
might alter -SYN aggregation as well as the concurrent measure-
ment of changes in cell viability. This assay allows identiﬁcation of
both inhibitors and stimulators of -SYN aggregation and can also
be used to study -SYN aggregation itself.
2. Materials and methods
2.1. Cell culture
Human SH-SY5Y neuroblastoma cells were grown in Dulbecco’s
modiﬁed Eagle’s medium (DMEM) (Gibco-BRL, Life Technologies,
Cat No. 31966047), 50mg/ml gentamycin (Gibco-BRL, Life Tech-
nologies, Cat No. 15750045) and 1% non essential amino acids
(Gibco-BRL, Life Technologies, Cat No. 11140068) (referred to
herein as DMEM-complete) at 37 ◦C and 5% CO2 in a humidiﬁed
atmosphere.
2.2. Antibodies and other reagents
DAPI (4′,6-diamidino-2-phenylindole, Cat No. D9592), propid-
ium iodide (PI, Cat No. P4170), staurosporine (Cat No. S6942) and
FK506 (tacrolimus, Cat No. F4679) were purchased from Sigma-
Aldrich (Bornem, Belgium). FTI-277 was a kind gift from Janssen
Pharmaceutica (Beerse, Belgium). 1mg/ml stock solutions of PI
(40×) and DAPI (10,000×) were made in H2O. Staurosporine and
FTI-277 were dissolved in DMSO (Sigma-Aldrich, Cat No. 276855)
in a stock solution of 1mM. FK506 was dissolved in DMSO in
a stock solution of 10mM (1000×). For Western blot the anti-
human anti--SYN antibody 15G7 (1:100, Enzo Life Sciences, Cat
No. ALX-804-258) was used and a mouse monoclonal anti--
tubulin antibody (1:50,000, Sigma, Cat No. T5168) was used as
internal loading control. The rabbit polyclonal antibody against
cleaved caspase-3 was purchased from Cell Signaling Technology
(Danvers, MA, USA Cat No. 9661s), and used at 1:500 and 1:1000
for immunocytochemistry (ICC) andwestern blotting, respectively.
The cytotoxicity detection kit was purchased from Roche (Cat No.
11644793001) and the lactate dehydrogenase activity was deter-
mined according to the manufacturer’s instructions.
2.3. Generation of polyclonal stable overexpression cell lines
using lentiviral vectors
cDNA encoding-SYN was cloned into the pCHMWS-IRES-puro
lentiviral (LV) transfer plasmid. LV vectors encoding -SYN under
control of the cytomegalovirus (CMV) promoter were prepared in
house as previously described using the triple transfection method
with a transfer plasmid (Geraerts et al., 2005), an envelope plasmid
encodingVSV-Gandapackagingplasmid (p8.91). The LVconstructs
allowed co-expression of the puromycin resistance gene from the
same transcript as the -SYN cDNA via an internal ribosome entry
site (IRES). The LV titer was determined via measurement of p24
antigen content by an enzyme linked immunosorbent assay (HIV-1
p24 ELISA kit, XpressBio Europe Cat No. XB-1000). Prior to trans-
duction, 1.5×105 SH-SY5Y cells were plated in a 24-well plate and
grown in DMEM-complete. The following day, vector was applied
to the cells for 2 days, after which the vector-containing medium
was replaced by DMEM-complete with 1g/ml puromycin (Invi-
trogen, CatNo. ANT-PR-1). Overexpressionof-SYNwas controlled
via western blot.2.4. Western blotting
Cells were plated in 6-well plates (2×106 cells/well). After 1
day, cells were washed with PBS (Lonza, Cat No. BE15-512D) and
161
162
l
S
t
t
c
d
e
d
w
i
w
S
c
s
2
e
w
c
N
N
ﬁ
t
w
r
w
C
2
3
1
(
C
p
A
f
T
P
i
t
2
b
M
A
n
c
w
2
c
t
2
w
i
a
a
n
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278ysed in 200l 1% SDS solution (Sigma-Aldrich Cat No. L3771). The
DS cell extracts were boiled for 2min, followed by 6 passages
hrough a 30G insulin syringe. After determination of protein con-
ent by a BCA assay (Perbio Science Cat No. 23225ZZ), cell extracts
ontaining 20g of total protein were separated on 4–12% sodium
odecyl sulfate-polyacrylamide gels (NUPAGE, Thermo Fisher Sci-
ntiﬁc Cat No. NP0323BOX) and electroblotted onto polyvinylidene
iﬂuoride membranes (Bio-Rad, Cat No. 162-0177). Membranes
ere blocked with 4% milk, and incubated with speciﬁc antibod-
es against -SYN, cleaved caspase-3 and/or -tubulin. Detection
as performed using chemiluminescence (ECL+-kit, Thermo Fisher
cientiﬁc, Cat No. 32132X3), a horseradish peroxidase (HRP)-
onjugated secondary antibody (Dako) and the LAS-4000 imaging
ystem (Fujiﬁlm, Dusseldorf, Germany).
.5. Synucleinopathy cell culture model
We used the cell culture model described by Ostrerova-Golts
t al. to induce -SYN aggregation with a few modiﬁcations. Cells
ere plated in 96-well plates (1.5×104 cells/well). The next day,
ells were treated for 72h with 100M H2O2 (Sigma-Aldrich Cat
o. H1009) and 5mM freshly prepared FeCl2 (Sigma-Aldrich Cat
o. 372870) in DMEM-complete and ﬁltered through a 0.22m
lter (Merck Millipore Cat No. SLGS033SS). Different concentra-
ions of FTI-277 (a stock solution in DMSO was diluted 1000-fold)
ere added to this stress-inducing medium. The control condition
eceived the same amount of DMSO. After three days, cells were
ashed with PBS and ﬁxed with 4% formaldehyde (Sigma-Aldrich
at No. F1635) for 15min. Cells were stored in PBS until analysis.
.6. Immunocytochemistry
First, cells were stained with 1×PI in DMEM-complete for
0min. Afterwards, cells were ﬁxed with 4% formaldehyde for
5min, after 3 washes with PBS. After a blocking step with 2% BSA
Sigma-AldrichCatNo. A2153) and0.05%Tween-20 (Sigma-Aldrich
at No. P9416) in PBS for 1h, cells were incubated overnight with
rimary antibody against cleaved caspase-3 in PBS plus 1% BSA.
fter washing twice with PBS for 15min, the cells were incubated
or 1h with a secondary Alexa Fluor 488-conjugated antibody (Life
echnologies, Cat No. A11070). After a second washing step with
BS (2 times 15min), the cells were incubated with DAPI (1:10,000
n PBS) for 1h and washed again with PBS twice and analyzed with
he IN Cell Analyzer 2000 (GE Healthcare, Chalfont St. Giles, UK).
.7. Thioﬂavin S/DAPI staining of cells
After oxidative stress induction andﬁxation, the cellswere incu-
ated with freshly prepared and ﬁltered (0.45m ﬁlter, Merck
illipore Cat No. SLHA033SS) 0.1% Thioﬂavin S (Thio S, Sigma-
ldrich Cat No. T1892) for 20min and washed twice with 70%
on-denatured ethanol (Sigma-Aldrich 02877) for 2min. Next, the
ells in thewellswere incubatedwithDAPI (1:10,000 in PBS). Plates
ere analysed using the IN Cell Analyzer 2000 within 1 day.
.8. High-content analysis of ˛-SYN aggregation
To quantify -SYN aggregation in our synucleinopathy cell
ulture model, we used the IN Cell Analyzer 2000 and IN Cell Inves-
igator software (GE Healthcare) as described before (Gerard et al.,
010). For each cell line tested, six independent measurements
ere examined to obtain statistical information. Microscopicmages of cell samples in a 96-well plate were generated in an
utomated manner with a 10× objective. After pre-deﬁning the
utofocusing step, three imageswere taken in three different chan-
els (light source: xenon lamp) for each well: (1) DAPI staining3
(excitation ﬁlter at 360nm and emission ﬁlter at 460nm, expo-
sure time 250–500ms), (2) Thio S staining (excitation at 480nm,
emission at 535nm, exposure time 1000–2000ms) and (3) bright
ﬁeld image (exposure time 50ms). This way, a total of 200–1000
cells were imaged and analyzed in each well. Images were fur-
ther analyzed with a user-deﬁned multi-target analysis protocol
of the IN Cell Investigator software (IN Cell Analyzer Worksta-
tion). Information of four different parameters was extracted
based on the respective channels used: (1) nucleus identiﬁcation
(wavelength 1), (2) cytoplasm identiﬁcation (wavelength 2), and
(3) inclusions in the cytoplasm (wavelength 2). Before analysis,
segmentation parameters were pre-set and optimized, when nec-
essary, to ensure correct detection of all image features. Overall,
nuclei were detected via the DAPI staining (wavelength 1) with
a top-hat mask. The minimal area and sensitivity for detection
were, respectively, set at 20m2 and 60–80. The cytoplasm was
detected via the background Thio S staining (wavelength 2) with
a multiscale top-hat mask. The characteristic detection area and
the detection sensitivity were, respectively, set at 20m2 and
60–80. -SYN inclusions were detected in the cytoplasm based
on increased ﬂuorescence of the Thio S staining compared with
the background intensity. Again, a multiscale top-hat mask was
applied. Upper and lower limit for granule size (10 scales) were,
respectively, 1m and 10m, while detection sensitivity was set
to 60–80. Advanced sensitivity setting was 1.2–2.4. Data ﬁles were
exported in MS Excel (Redmont, CA, US) and contained informa-
tion about -SYN inclusion count, mean/total area and intensity.
As further mentioned and as indicated in Section 3, the HCA of
-SYN aggregation could be expanded with cell death parameters
(see below).
2.9. Manual counting of ˛-SYN aggregation
Intracellular ﬁbrillar-SYN aggregates were detected after Thio
S staining with a 488-argon ion laser. For each condition, at least
eight independent samples (glass plates) were assayed (8≤n≤16
for all experiments). Three confocal images were acquired of
each sample with an inverted confocal ﬂuorescence microscope
(LSM 510 Meta; Carl Zeiss) after staining and ∼100 cells were
determined to be aggregate positive or negative. The conditions
of the experiment were blinded to the investigator scoring the
cells.
2.10. High-content analysis of cell death
To quantify cell death in our synucleinopathy cell culturemodel,
we used the IN Cell Analyzer 2000 and the IN Cell Investigator soft-
ware, comparable to the analysis of -SYN aggregation. For each
condition tested, at least 6 independentmeasurementswere exam-
ined to obtain statistical signiﬁcance. Again, microscopy images of
cell samples in a 96-well plate were generated in an automated
manner using the 10× objective. After pre-deﬁning the autofocus-
ing step, three images were acquired in four different channels
(xenon lamp) for each well: (1) DAPI staining (excitation ﬁlter at
360nm and emission ﬁlter at 460nm, exposure time 500ms), (2)
immunocytochemical staining for cleaved caspase 3 (excitation at
480nm,emissionat535nm,exposure time1500ms), (3)PI staining
(excitation at 535nm, emission at 620nm, exposure time 500ms)
and (4) bright ﬁeld image (exposure time 50ms). This way, a total
of 250–1000 cells were imaged and analyzed in each well. Images
were further analyzed with a user-deﬁned multi-target analysis
protocol of the INCell Investigator software (INCell AnalyzerWork-
station). Information of ﬁve different parameters was extracted
based on the respective channels used: (1) nucleus identiﬁcation
(wavelength 1), (2) cytoplasm identiﬁcation (wavelength 2), (3)
inclusions in the cytoplasm (wavelength 2), (4) inclusions in the
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395uclei and (5) PI staining (wavelength 3). Before analysis, segmen-
ation parameters were pre-set and optimized, when necessary, to
nsure correct detection of all image features. Nucleiwere detected
s described for the analysis of -SYN aggregation. The cytoplasm
as detected via the background immunocytochemical staining
or cleaved caspase 3 (wavelength 2) with a multiscale top-hat
ask. The characteristic detection area and the detection sensitiv-
ty were, respectively, set at 20m2 and 60–80. Activated caspase
was detected in the cytoplasmbased on increased ﬂuorescence of
he immunocytochemical staining compared with the background
ntensity. Again, a multiscale top-hat mask was applied. Upper and
ower limit for granule size (10 scales)were, respectively, 1mand
0m, while detection sensitivity was set to 60. Possible apop-
otic inclusions in the nucleus were detected via the DAPI staining
wavelength 1) with a multiscale top-hat mask. Upper and lower
imit for granule size (7 scales)were, respectively, 1mand20m,
hile detection sensitivity was set to 50–60. Advanced sensitivity
arameter was set to 5–9. PI staining (reference 1, wavelength 3)
as detected in the nuclei. Data ﬁles were exported in MS Excel
ormat and contained information about nucleus area, apoptotic
nd activated caspase 3 inclusion count,mean/total area and inten-
ity. Cells were counted positive for PI when ﬂuorescence intensity
xceeded a threshold value, which was ﬁxed after visual scoring of
he cells.
.11. High-content data analysis and statistical analysis
All information from the high-content analysis was exported
o MS Excel as mentioned in Section 2.10. Per cell, the following
arameters were further evaluated for both -SYN aggregation
cytoplasmic inclusions) and late apoptosis (nuclear inclusions):
i) presence, (ii) count (if present), (iii) intensity, (iv) mean area,
nd (v) total area of the inclusions. To analyze these data, a macro
visual basic) was written, which ﬁrst divided the cells according
o the well in which they were imaged (A1-H12 of a 96-well plate).
ext, the parameters, which had to be analyzed were chosen. If the
resence of inclusions (cytoplasmic or nuclear) was evaluated, this
as determined to be true if the count of inclusions was equal to or
arger than 1. This resulted in a fraction of inclusion-positive cells
er well. In the proportion of cells containing inclusions, the 25, 50
nd 75 percentiles of the count, intensity and area of inclusionswas
etermined per well.
For more detailed studies, additional parameters were eval-
ated: nuclear size and/or mean intensity of the Thio S, DAPI,
ctivated caspase 3 or PI staining. These evaluations were ﬁt in the
acro as described abovewith some adaptations. To determine the
ean Thio S and DAPI intensity, the mean (cytoplasmic or nuclear)
ntensity of the respective dyes was determined for all the cells,
er analyzed well. To determine PI staining, a cut-off ﬂuorescence
ntensitywas determined by the researcher abovewhich cellswere
learly PI positive. Per well, the proportion of cells above the cut-
ff was determined. To determine activated caspase 3 staining, the
ame procedure as for the detection of -SYN aggregate (Thio S)
ositive cells was followed.
For all these parameters, the analysis resulted in an (average)
alue per well. All wells representing a condition were averaged
nd the SEM was determined. In order to perform a powerful
tatistical analysis, data from different experiments were taken
nto account. All statistical analyses were performed in GraphPad
rism 5.0 (San Diego, CA, USA). An ANOVA followed by Dunnet or
onferroni post test determined the statistical difference between
he conditions. In case of non-normality, the non-parametric
quivalent (Kruskal–Wallis) was chosen, followed by Dunn’s test.
-Value <0.05 is indicated by *, p<0.01 by ** and p<0.001 by ***.2.12. Three-day uniformity plate assay
The variability of the HCA assay was evaluated with a plate uni-
formity study that was run over 3 days to assess uniformity and
separation of signals. SH-SY5Y cells overexpressing -SYN were
plated in a 96-well plate (1.5×104 cells/well). To achieve the mini-
mum (Min), maximum (Max) and intermediate (Mid) signals, cells
were treated without (Min, 0.1% DMSO) or with oxidative stress
(5mM FeCl2, 100M H2O2 and 0.1% DMSO) with (Mid) or without
(Max) 10M FK506 the following day. After 72h, cells were ﬁxed,
stained with Thio S and analyzed. Next, the following statistical
parameters were calculated for each plate:
- mean (AVG), standard deviation (SD), and coefﬁcient of variation
(CV) of the mean for each signal (Max, Min and Mid). The accep-
tance criteria are that the CV’s of each signal be less than or equal
to 20%.
- for each of the “Mid”-signal wells, a percent
activity for FK506 and SD were calculated: %Activ-
ity = (wellmid −AVGmin)/(AVGmin −AVGmax)×100
The acceptance criterion is SDmid≤20 on all plates.
Signal Window (SW) and Z′ factor (Z′) for each plate were calcu-
lated as described below. The acceptance criterion was SW≥2 and
Z′ ≥0.4 on all plates.
The formula for the signal window is:
SW =
(
AVGmax − 3SDmax/√n
)
−
(
AVGmin + 3SDmin/
√
n
)
SDmax/
√
n
where n is the number of replicates of the test substance that is
used for the assay.
Z′ factor formula is:
Z′ =
(
AVGmax − 3SDmax/√n
)
−
(
AVGmin + 3SDmin/
√
n
)
AVGmax − AVGmin
3. Results
3.1. Optimization of a high-content assay for quantiﬁcation of
˛-SYN aggregates and apoptosis in cell culture
We previously developed a cell culture model to induce -SYN
aggregation and cell death, in which SH-SY5Y neuroblastoma cells
overexpressing -SYN were exposed to oxidative stress conditions
using H2O2 and FeCl2 (Fig. 1A). After 3 days of treatment, -SYN
inclusions were visualized by Thio S staining (Fig. 1B, arrows)
and apoptotic cells were identiﬁed by the intensity of DAPI stain-
ing. Now we optimized a multiparametric high-content method
to speed up the quantiﬁcation of -SYN inclusions and cell death
formation in our cell culture model. The assay is based on the
automated generation of ﬂuorescence microscopy images of cell
samples in amulti-well plate format, followed by automated image
analysis. Six independent samples are examined for each cell line
and on average 500–1000 cells are analyzed in each well. The cells
are identiﬁed via DAPI nuclear staining (Fig. 1C, upper panel). The
cytoplasm is detected based on the background of Thio S stain-
ing and -SYN aggregates were determined based on the presence
of high intensity spots in the cytoplasm of several cells after Thio
S staining (Fig. 1C, middle panel, yellow marker). Apoptotic cells
were quantiﬁed by identifying spots of higher intensity in the DAPI
staining (Fig. 1C, upper panel, pink marker).In order to further validate this assay, we decided to optimize
several parameters that induce -SYN aggregation and cell death.
Therefore, we plated SH-SY5Y cells overexpressing -SYN in 96-
well plates and we exposed them to increasing concentrations of
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399
5Fig. 1. Optimization of a high-content assay tomeasure˛-SYN aggregation and cell death in SH-SY5Y neuroblastoma cells. (A) Schematic representation of the synucleinopathy cell
culture model. (B) Fluorescent microscopic image of Thio S-stained-SYN overexpressing SH-SY5Y cells that were subjected for three days to oxidative stress. Based on these
images, the number of aggregate-positive and aggregate-negative cells was determined. Scale bar indicates 10m. (C) Fluorescent microscopic image of Thio S/DAPI-stained
SH-SY5Y cells acquired with the IN cell analyzer. Upper panels: DAPI staining, middle panels: Thio S staining, lower panels: bright ﬁeld image. Left panels: pictures without
markers, right panels: identical pictures with markers. Blue marker: nucleus, green marker: cytoplasm, yellow marker: Thio S-positive -SYN aggregates, pink marker:
apoptotic inclusions. Scale bars indicate 10m. High-content analysis of -SYN inclusion formation and apoptosis in SH-SY5Y cells exposed to increasing concentrations of
FeCl2 (D) and H2O2 (E). Mean and SEM are shown for each condition (n=3), * p-values of -SYN aggregation; # p-values of -SYN-induced apoptosis. High-content analysis
of -SYN aggregates ((F) light grey bars) -SYN induced apoptosis ((G) light grey bars) with different cell seeding densities. As negative control, cells were not subjected to
oxidative stress (dark grey bars). Mean and SEM are shown for each condition (n=6). (For interpretation of the references to color in this ﬁgure legend, the reader is referred
to the web version of this article.)
6Fig. 2. ˛-SYN aggregation is dependent on the ˛-SYN expression level. (A) Western blot showing dose-dependent expression of -SYN after transduction of SH-SY5Y cells with
different dilutions of -SYN LV vector. In each lane, cell extract containing 20g of total protein was loaded. Upper panel: -SYN expression was visualized in SH-SY5Y cells.
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455egative control (Lane 5), cells transduced with 1/1 (Lane 1), 1/3 (Lane 2), 1/9 (Lan
ontrol. High-content analysis of -SYN aggregation (B) and apoptosis (C) in SH-SY
or each condition (n=6).
eCl2 and H2O2. Untreated cells were included as a negative con-
rol. Treatment with FeCl2 induced a dose-dependent formation of
-SYN aggregates in the cells, in parallel with a dose-dependent
ellular toxicity (Fig. 1D). Therefore, 5mM of FeCl2 was deﬁned
s the optimal concentration to promote -SYN aggregation and
ell death without inducing an extreme toxicity. In addition H2O2
s required to increase -SYN inclusion formation and apoptosis
n SH-SY5Y cells, but a concentration of 25M was sufﬁcient for
he induction, without a clear dose-dependent effect up to 200M
Fig. 1E). Hence, we used 100M of H2O2 for further experiments
o ensure a clear formation of -SYN inclusions and cell death.
Next, we evaluated the effect of cell density on -SYN aggre-
ation and cell death. Different numbers of cells were plated in a
6-well plate to identify the optimal cell seeding density for the
ssay. No difference in the percentage of cells with -SYN aggre-
ates was detected if 1×104, 1.5×104, 2×104 or 2.5×104 cells
er well were plated (Fig. 1F). When 5×103 cells per well were
eeded, an increase in -SYN aggregation was observed, but most
f the cells were killed after the oxidative stress treatment. -SYN
nduced apoptosis decreased in parallel with the increment of cell
eeding density (Fig. 1G). Therefore, we decided to Plate 1.5×104
ells per well for all further experiments, to get a proper induction
f-SYN aggregation and apoptosis and an appropriate conﬂuence
f cells 3 days after plating.
.2. Evaluation of the correlation between ˛-SYN expression
evels and aggregation in the high-content assayAs stated in the introduction, increased expression of WT -
YN due to locus duplication (Chartier-Harlin et al., 2004; Ibanez
t al., 2004) or triplication might enhance the risk of developing
D. Importantly, amajor implication fromtheseobservations is thatr 1/27 (Lane 4) dilution of -SYN LV. Lower panel, -tubulin is detected as loading
lls overexpressing different concentrations of -SYN. Average and SEM are shown
-SYN levels areanotabledeterminant in the severityof theparkin-
sonian phenotype. To further validate our HCAmethod, we veriﬁed
whether we could observe a similar effect in our synucleinopathy
model. Therefore, we generated stable cell lines by transduction of
SH-SY5Y cellswith different dilutions of an-SYNencoding LVvec-
tor, starting froman initial vector titer of 5.24×107 pg/mL.Western
blot conﬁrmed the dose-dependent overexpression of the -SYN
protein (Fig. 2A). To address whether -SYN dosage inﬂuences the
formation of -SYN inclusions and -SYN toxicity, we subjected
the different -SYN overexpressing cell lines to oxidative stress
for three days and quantiﬁed the -SYN inclusions using Thio S
staining (Fig. 2B) and apoptotic cells by DAPI staining (Fig. 2C). The
percentage of aggregate-positive cells and apoptotic cells increased
signiﬁcantly with increasing -SYN expression levels, revealing a
positive correlation between-SYN aggregation and cell death and
the amount of -SYN protein.
3.3. Expansion to a multi-parametric assay for apoptotic cell
death
As combining a cell-based -SYN aggregation assay with read-
outs for apoptosis might provide important insights into the role
of aggregate formation in cell death processes, we expanded our
automated test system with several markers of cell death. To opti-
mize the measurement of these cell death parameters, we treated
-SYN overexpressing SH-SY5Y cells for 17h with various concen-
trations of staurosporine, a protein kinase inhibitor that has been
shown before to induce apoptosis in different cell types. After stau-
rosporine treatment, the cells were (1) stainedwith PI, amarker for
loss of plasma membrane integrity, (2) ﬁxed and stained immuno-
cytochemically for cleaved caspase-3, an early marker of apoptosis
and (3) stained with DAPI to quantify nucleus condensation and
456
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7Fig. 3. Quantiﬁcation of apoptoticmarkers in SH-SY5Y neuroblastoma cells after staurosporine treatment. (A) Fluorescent images of the IN Cell Analyzer after 17h of staurosporine
treatment. Examples of nucleus detection via DAPI staining (1), cleaved caspase-3 detection via immunocytochemical staining (2), propidium iodide staining (3), and bright
ﬁeld image (4). Arrows depict apoptotic cells. (B) Western blot showing expression of cleaved caspase-3 after 17h of staurosporine treatment. In each lane, cell extract
containing 10g of total protein was loaded. Upper panel: cleaved caspase-3 expression was visualized in SH-SY5Y cells. Cells treated with 500nM (Lane 1); 250nM (Lane
2); 125nM (Lane 3); 62.5nM (Lane 4) or 31.25nM (Lane 5) of staurosporine, negative controls (with and without DMSO, respectively, Lane 6 and 7). Lower panel, -tubulin
is detected as loading control. C, High-content analysis of percentage of cells with nucleus fragmentation, caspase-3 activation and loss of plasma membrane integrity in
SH-SY5Y cells after 17h of staurosporine treatment. Error bars show the SEM (n=6). (D) High-content analysis of nucleus fragmentation and quantiﬁcation of LDH activity
after 17h of staurosporine treatment. Error bars show the SEM (n=3). (E) and (F), High-content analysis of number (E), and intensity (F) of DAPI-positive nuclear inclusions
per nucleus. Median and SEM are shown for each condition (n=6). (G) High-content analysis of nuclear size based on DAPI staining. Mean and SEM are shown for each
condition (n=6).
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Table 1
Three-day plate uniformity study for HCA synucleinopathy cell culture assay. Overview
of the statistical analysis performed on three independent experiments run in three
days to assess the variability and reproducibility of the HCA cell culture assay. The
plate acceptance criteria are described in the ﬁrst column of the table. In every plate,
the calculated statistical parameters arewithin the acceptable limits. CV: coefﬁcient
of variation of the mean; SD: standard deviation; Z′: Z-prime factor; SW: signal
window; SSMD: strictly standardizedmeandifference; AVG:mean;max:maximum
signal; min: minimum signal; mid: intermediate signal.
Plate 1 Plate 2 Plate 3
Intra-plate acceptance criteria
CVmax ≤20% 4% 3% 4%
CVmin ≤20% 4% 8% 7%
Normalized SDmid ≤20 11.98 12.98 9.13
Z′ ≥0.4 0.81 0.83 0.73
SW≥2 16.48 23.15 12.52
SSMD≥3 4.35 5.31 3.39
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561ucleus fragmentation, two late events in apoptosis. Then, accord-
ng to predeﬁned parameters, pictures were taken of each well
Fig. 3A 1–4). Based on the DAPI nuclear staining, the nuclear size
nd thepresenceof highlyﬂuorescent nuclear fragmentswereused
o quantify nucleus condensation and fragmentation, respectively,
s described before (Gerard et al., 2010) (Fig. 3A 1). Simultaneously,
leaved caspase-3 and PI staining were identiﬁed by the software.
aspase-3 activation was detected in the cytoplasm based on spots
ith increased ﬂuorescence compared to background ﬂuorescence
Fig. 3A 2). PI staining was detected by its overall intensity in the
ucleus (Fig. 3A3). Before analysis, itwas essential to verify the cor-
ect detection of these image features to limit the detection of false
ositives or negatives. Once the optimal parameters for segment-
ng were set, they were applied to all images in a standardized and
bjectivemanner. Our image acquisition and analysis protocols are
escribed more in detail in Section 2.
Fig. 3C shows that staurosporine provoked apoptosis in a dose-
ependent way. All three parameters increased after treatment.
or low staurosporine concentrations, cleaved caspase-3 seemed
he most sensitive apoptosis parameter, while DAPI-based inclu-
ions were only detected at higher concentrations, but exhibited a
lear dose-dependency in the full staurosporine range; activated
aspase-3 reached a plateau at high staurosporine concentra-
ions. Western blot conﬁrmed the dose-dependent induction of
leaved caspase-3 (Fig. 3B). Next, to better estimate the accuracy
f the cell death detection we compared our automated method
o a cytotoxicity detection assay that measures lactate dehydro-
enase (LDH) activity released from damaged cells. We exposed
-SYN overexpressing SH-SY5Y cells to increasing concentrations
f staurosporine and we quantiﬁed nucleus fragmentation and
DH activity after 17h. Fig. 3D shows that both LDH activity and
ucleus fragmentation increase in a dose-dependent way after
taurosporine treatment and no statistical difference was detected
etween the two methods.
When looking in further detail to the DAPI staining, more infor-
ation was extracted beyond the percentage of apoptotic cells. In
ig. 3E and F, respectively, the number and intensity of nuclear
reas with intense DAPI staining are provided. These also increase
n a dose-dependent manner with staurosporine treatment. We
urther noticed that nuclear size (Fig. 3G), a marker for nuclear
ondensation, is inversely correlatedwith increasing staurosporine
oncentrations.
.4. Direct comparison of manual counting and the high-content
ssay for measuring the inhibition of ˛-SYN aggregation by a
arnesyl transferase inhibitor
Since farnesylation, a posttranslational modiﬁcation, has been
mplied in -SYN neurotoxicity (Liu et al., 2009), we studied the
ffect of a farnesyl transferase inhibitor (FTI) 277 on -SYN aggre-
ation and cell death, to further validate our cell culture assay. We
ncubated human neuroblastoma SH-SY5Y cells for three dayswith
eCl2, H2O2 and different concentrations of FTI-277 andwe quanti-
ed the -SYN inclusions using Thio S staining and apoptotic cells
y DAPI staining. Next, we compared the number of cells with Thio
-positive aggregates, detected by blinded manual counting after
onfocal microscopy (Fig. 4A) or by HCA (Fig. 4B). With both man-
al detection of -SYN aggregation and automated HCA, we could
learly detect a concentration-dependent effect of FTI-277 on the
ercentage of cells containing -SYN ﬁbrils. Although the abso-
ute number of aggregate-positive cells differed between the two
ethods, the apparent IC50 wasbetween1and10nMforbothman-
al and HCA. Moreover, HCA showed that the decrease in -SYN
ggregation coincided with a beneﬁcial effect on cell death.Inter-plate acceptance criteria
Normalized AVGmid ≤2-fold
difference between plates
26.57 25.29 20.16
3.5. Validation of the suitability of the high-content assay for
drug screening
We previously tested the effect of FK506, an immunophilin
ligand that exhibits signiﬁcant neuroregenerative and neuropro-
tective properties in models for neurodegeneration, in our cellular
-SYN aggregation model. We showed that FK506 decreases the
number of -SYN aggregates and protects against cell death
(Deleersnijder et al., 2011; Gerard et al., 2010).
To further validate the assay for drug screening, we performed a
3-day plate uniformity study to evaluate the robustness and repro-
ducibility of our HCA assay (Iversen et al., 2012). Uniformity assays
were performed at themaximum (Max) andminimum (Min) signal
to ensure that the signal window is adequate to detect active com-
pounds during a screen. We ran three independent experiments
over 3 days, using three different types of signals to determine the
intra- and inter-plate variability of the assay. To obtain theMax and
Min signals, -SYN overexpressing SH-SY5Y cells were exposed to
high levels of oxidative stress or no oxidative stress, respectively.
Cells were treated with FK506 in oxidative stress conditions to
produce an intermediate signal (Mid), which estimates the signal
variabilityat somepointbetween theMaxandMinsignals.Next,we
measured several statistical parameters inorder to verify the repro-
ducibility of our HCA assay. We calculated the signal window (SW),
Z factors (Z′) and strictly standardized mean differences (SSMD) of
each plate to evaluate the signal separation between Max and Min.
Every plate displayed SWand SSMDhigher than the recommended
value (2 and 3, respectively) and a Z′ higher than 0.7, pointing at
an excellent window for screening of inhibitors and stimulators
of -SYN aggregation (Table 1). Moreover, the coefﬁcient of vari-
ation (CV) of the Max and Min signal was always lower than 20%
and the standard deviation (SD) of the Mid signal percent activity
values was lower than 20 in all plates. Finally, there was no sig-
niﬁcant variability among plates, since the difference between the
normalized Mid signal was always lower than two-fold (Table 1),
demonstrating the robust reproducibility of our assay.
4. Discussion
In recent years, an increasing number of studies has reported
the use of high-content analysis (HCA) (Blackmore et al., 2010;
Boyd et al., 2014; Radio, 2012) because HCA is an excellent method
to bridge the gap between in vitro and in vivo disease model
systems. in vitro systems allow screening of large numbers of
molecules/conditions, but have lowphysiological relevance. In vivo
models aremuchmorephysiologically relevant, but are labour- and
cost-intensiveand thereforeoften less suited forprimary screening.
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9Fig. 4. Comparison of manual counting and high-content analysis of ˛-SYN aggregation after treatment with FTI 277. (A) Aggregate counts on confocal ﬂuorescent images of
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649ells treated with different concentrations of FTI-277 show a concentration-depend
nalysis shows a decrease in the percentage of cells containing -SYN aggregates (
ncreasing concentration of FTI-277 is applied to the cells. Error bars show the SEM
nly a few reports have beenmade on the use ofHCA in Parkinson’s
isease (PD) research in order to analyze-SYN content and-SYN
ell-to-cell transfer or to screen for regulators of parkin translo-
ation and inhibitors of rotenone toxicity (Bidinosti et al., 2012;
itzgerald et al., 2003; Hansen et al., 2011; Hasson et al., 2013;
eyes et al., 2014) Previously, we described a neuronal cell-based
ssay that measures -SYN aggregation together with apoptotic
ell death and we used this assay to investigate the role of FK506
inding proteins (FKBPs) on -SYN aggregation and neurodegen-
ration (Deleersnijder et al., 2013, 2011; Gerard et al., 2010). Here,
e describe the optimization and validation of a HCA,which can be
sed for the identiﬁcation of potential inhibitors of -SYN aggre-
ation.
The ﬁrst step in the optimization process was the establish-
ent of the most efﬁcient oxidative stress conditions and cell
eeding density for 96-well plates, to induce -SYN aggregation
n human neuroblastoma cells overexpressing-SYN (Fig. 1). Next,
e showed that the percentage of cells with-SYN inclusions after
xidative stress treatment depends on the expression level of -
YN in the cells (Fig. 2). Since in PDpatients an increased expression
f-SYN,due togainof functionmutations, duplicationsor triplica-
ions of the-SYN gene, is associatedwith amore severe pathology
nd elevated -SYN aggregation, this result conﬁrmed the validity
f our assay.Moreover, distinct statistical indices (SW, Z-factor and
V) calculated in three experiment runs on different days clearly
ttested the reproducibility and robustness of our assay (Table 1).
n order to verify that each experiment has worked properly, we
lways included untreated cells and cells exposed to oxidative
tress treatment as control cells.We considered an experiment suc-
essful ifwecouldobserveat least a2-folddifferencebetween these
egative and positive control cells. Additionally, when testing the
ffect of compounds on -SYN aggregation or late apoptosis, we
lways include in each plate cells treated with FK506 as a positive
ontrol. We have shown previously that FK506 decreases the num-
er of -SYN aggregates and apoptotic cells (Deleersnijder et al.,
011; Gerard et al., 2010).Moreover, since the cell density is crucial
or an accurate performance of the assay, we veriﬁed that the cell
rowth would be comparable in the different experimental condi-
ions and we included in the analysis wells with a total number of
00–1000 cells.Taking advantage of the multiparametric nature of HCA assays,
e next included read-outs for apoptosis in our assay, since this
s an important end-point in neuroscience research (Kroemer
t al., 2009). We expanded our automated test system to measurecrease of -SYN aggregation. Error bars show the SEM (n=8). (B) Automated image
cant from 100nM) as well as apoptotic inclusions (signiﬁcant from 1nM) when an
).
caspase-3 activation (via immunocytochemical staining), nuclear
fragmentation (via DAPI staining) and loss of an intact plasma
membrane (via PI staining) as markers of cell death. In a proof-
of-principle experiment, we demonstrated that staurosporine, a
known inducer of apoptosis, dose-dependently decreased cell via-
bility as shown by caspase-3 activation, nuclear fragmentation and
lossofplasmamembrane integrity (Fig. 3). Althoughstaurosporine-
induced apoptosis was adequately reﬂected in the number of cells
positive for, respectively, activated caspase-3, membrane integrity
loss and nucleus fragmentation, the latter correlated best with -
SYN aggregation. Combined with the fact that DAPI staining is less
time consuming,wepropose nuclear condensation as the preferred
marker to follow -SYN toxicity in our HCA system. Moreover, we
showed that the automated quantiﬁcation of cell death in our assay
correlates with the detection of LDH activity released by damaged
cells after staurosporine treatment, demonstrating the ﬁdelity of
our method.
Next, for the validation of the high-content assay we also
included an experimental comparison with standard methods.
Therefore, we compared microscopic counting of -SYN aggrega-
tion with our high-content method, after treatment of SH-SY5Y
cells with the commercially available farnesyl transferase inhibitor
FTI-277 in our synucleinopathy cell culturemodel. Previous reports
already associated farnesylation to PD (Liu et al., 2009). More
speciﬁcally, it was shown that UCH-L1, a protein linked to PD
(Elbaz et al., 2003; Maraganore et al., 2004; Momose et al., 2002;
Wintermeyer et al., 2000), Alzheimer’s disease (Xue and Jia, 2006)
and Huntington disease (Naze et al., 2002), migrates to the endo-
plasmic reticulum membrane after farnesylation. Furthermore, the
amount of membrane-associated UCH-L1 correlates with intracel-
lular -SYN levels and neurotoxicity. When UCH-L1 farnesylation
is chemically inhibited with FTI-277, -SYN levels are reduced
and neuronal cell viability is improved. The authors’ hypothe-
sis is that inhibition of UCH-L1 farnesylation may result in the
activation of a non-proteasomal pathway for -SYN degradation,
such as chaperone-mediated autophagy or macroautophagy. Here,
both manual and HCA of -SYN aggregation demonstrated that
FTI-277 treatment dose-dependently reduces the number -SYN
aggregate-positive cells in SH-SY5Y cells (Fig. 4). However, the
sensitivity to detect absolute numbers of -SYN aggregates was
higher for HCA (e.g. 35% versus 20% of -SYN aggregate-positive
cells for control DMSO condition in high-content analysis andman-
ual assessment, respectively). We believe this is likely due to an
underestimation of the percentage of -SYN aggregate-positive
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ells by microscopic counting, where small or less intense aggre-
ates might be overlooked. Moreover, for the manual analysis we
sed confocal images, therefore only aggregates in one optical
lane were visualized inside the cell. Furthermore, the quantiﬁca-
ion of the -SYN aggregate-positive cells in these images greatly
epends on the subjective estimation of the blinded observer. The
CA method overcomes these problems, since it counts -SYN
ggregates throughout the whole cell and objectively detects these
ggregates above a threshold of ﬂuorescence intensity. Another
dvantage of the HCA method is that it allows simultaneous quan-
iﬁcation of several parameters. For FTI-277, we also quantiﬁed
API-ﬂuorescence intensity as a measure of cell death; a posi-
ive correlation between -SYN aggregation and apoptosis was
etected (Fig. 4B). This is in agreement with the previous report
escribing that FTI-277 treatment protects against-SYN accumu-
ation and toxicity (Liu et al., 2009).In conclusion, we propose that
his HCA cellular assay will be widely applicable for PD research,
ot only for basic research on the mechanism of -SYN inclusion
ormation, but also to validate new compounds targeting -SYN
ggregation. Over the last decade, the transition of in vitro hits to
fﬁcacious compounds in more complex disease models in neu-
odegeneration research suffered from many unexpected failures
Varma et al., 2008). The major challenge in producing a successful
rug candidate for further preclinical development and ultimately
linical trials is, whether efﬁcacy in an in vitro assay can be trans-
ated to a whole-animal disease model. Our HCA neuronal assay is
ositioned in the middle of this drug discovery process, as it can
elp to bridge the gap between simpliﬁed in vitro -SYN aggre-
ation tests and the complex biological context of a PD animal
odel. Moreover, it is best suited for deciphering molecular mech-
nisms of pathological processes in a quantitative biology fashion.
e believe that ourHCAmethod canprovidemore predictive value
or in vivo beneﬁt and clinical potential, and additionally, is scal-
ble to evaluate larger numbers of compounds than animalmodels.
s such, it can be used as a secondary screen to rank hits from a
igh-throughput screen, before advancement into full preclinical
evelopment.
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